Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation

These data sustain the relevant role of molecular monitoring in MM patients undergoing NMT. MRD monitoring would assist physicians in making additional therapeutic decisions to better control this hematological malignancy.